As Walls Open, Drug Companies Close Facebook Pages
Drug companies continue to react to Facebook's policy shift this week that enables the public to comment on the walls of certain pharmaceutical pages.
Drug companies continue to react to Facebook’s policy shift this week that enables the public to comment on the walls of certain pharma pages.
While product or drug-specific pages continue to be closed to comments, Facebook on Monday started allowing the public to weigh in on the corporate pages of drug companies, as well as pages for patient-specific groups.
And that’s resulting in a number of pharma companies closing Facebook pages, or at the very least monitoring them more closely.
The issue is how much time these companies want to devote to monitoring and deleting inappropriate comments, since open walls may lead to the reporting of bad side effects or unfactual statements – which could raise concern from government regulators.
The
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in